Global Innovative Platforms (GIPL) Change in Accured Expenses (2020 - 2026)
Global Innovative Platforms' (GIPL) quarterly Change in Accured Expenses came in at -$5000.0 in Q1 2026, down 518.41% year-over-year from $1195.0 in Q1 2025, and down 66.67% quarter-over-quarter from -$3000.0 in Q4 2025.
Analysis
Global Innovative Platforms (GIPL) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Change in Accured Expenses across 7 years of filings, most recently posting -$5000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 518.41% year-over-year to -$5000.0; the TTM figure through Jun 2026 stood at -$31500.0 (down 173.94% YoY), while the FY2025 annual figure was -$30900.0, down 75.57% from the prior year.
- Change in Accured Expenses came in at -$5000.0 for Q1 2026 at Global Innovative Platforms, down from -$3000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $50000.0 in Q3 2023 to a low of -$32400.0 in Q4 2024.
- Average Change in Accured Expenses over 5 years is $1009.1, with a median of -$3000.0 recorded in 2025.
- Year-over-year, Change in Accured Expenses surged 125.43% in 2022 and tumbled 518.41% in 2026.
- Over 5 years, Change in Accured Expenses stood at -$5500.0 in 2022, then surged by 1009.09% to $50000.0 in 2023, then plunged by 164.8% to -$32400.0 in 2024, then surged by 90.74% to -$3000.0 in 2025, then plunged by 66.67% to -$5000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$5000.0 in Q1 2026, -$3000.0 in Q4 2025, and -$23500.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | - |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 142.00 Mn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | - |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 28.65 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Sep 30, 2025 | -23,500.00 |
| Jun 30, 2025 | 23,805.00 |
| Mar 31, 2025 | 1,195.00 |
| Dec 31, 2024 | -32,400.00 |
| Sep 30, 2023 | 50,000.00 |
| Jun 30, 2023 | -10,053.00 |
| Mar 31, 2023 | 10,053.00 |
| Jun 30, 2022 | -5,500.00 |
| Mar 31, 2022 | 5,500.00 |
| Sep 30, 2021 | 16,640.00 |
| Jun 30, 2021 | 10,850.00 |
| Mar 31, 2021 | -21,629.00 |
| Dec 31, 2020 | 15,000.00 |